Fresenius Medical Care (FMS) Tops Q3 EPS Views

Fresenius Medical Care (NYSE: FMS) reported Q3 EPS of $1.09, $0.57 better than the analyst estimate of $0.52. Revenue for the quarter came in at $4.6 billion versus the consensus estimate of $4.55 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Landstar System (LSTR) PT Raised to $186 at Stifel
• Caterpillar (CAT) PT Raised to $1,105 at Oppenheimer